ChiCTR2100053355 版本V1.8 版本创建时间2024/04/25 10:44:01 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100053355 

最近更新日期:

Date of Last Refreshed on:

2022-09-26 22:14:42 

注册时间:

Date of Registration:

2021-11-20 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

研究负责人与伦理审批文件内容不同,请确认。 基于fNRIS技术探讨针刺促醒意识障碍患者的机制

Public title:

Exploring the mechanism of acupuncture in patients with impaired consciousness based on fNRIS technology

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于多模态影像学特征识别的针刺促醒意识障碍患者疗效差异的临床评价和机制研究

Scientific title:

Clinical evaluation and mechanism study of therapeutic effect difference in patients with awakening disorder induced by acupuncture based on multi-modal imaging feature recognition

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiMCTR2200006658

申请注册联系人:

孙宁 

研究负责人:

刘沂潍 

Applicant:

Sun Ning 

Study leader:

Liu Yiwei 

申请注册联系人电话:

Applicant telephone:

+86 13261686476

研究负责人电话:

Study leader's telephone:

+86 18190824889

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

sunning91vip@126.com

研究负责人电子邮件:

Study leader's E-mail:

rliuyiwei@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国四川省成都市十二桥路37号

研究负责人通讯地址:

四川省成都市国学巷37号

Applicant address:

37 Shierqiao Road, Jinniu District, Chengdu, Sichuan, China

Study leader's address:

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

成都中医药大学

Applicant's institution:

Chengdu University of Traditional Chinese Medicine

研究负责人所在单位:

四川大学华西医院

Affiliation of the Leader:

West China Hospital of Sichuan University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

20201070

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

四川大学华西医院生物医学伦理审查委员会

Name of the ethic committee:

Ethics Committee on Biomedical Research of West China Hospital of Sichuan University

伦理委员会批准日期:

Date of approved by ethic committee:

2021-01-26 00:00:00

伦理委员会联系人:

左泽锦

Contact Name of the ethic committee:

Zuo Zejin

伦理委员会联系地址:

成都市国学巷37号

Contact Address of the ethic committee:

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

四川大学华西医院

Primary sponsor:

West China Hospital of Sichuan University

研究实施负责(组长)单位地址:

成都市国学巷37号

Primary sponsor's address:

37 Guoxue Lane, Wuhou District, Chengdu, Sichuan, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川

市(区县):

成都

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

四川大学华西医院

具体地址:

国学巷37号

Institution
hospital:

West China Hospital of Sichuan University

Address:

37 Guoxue Lane, Wuhou District

经费或物资来源:

四川省中医药管理局中医药科研专项课题(NO.2021MS055) 科技部国家重点研发计划“老年全周期康复技术体系与信息化管理研究”子课题:老年常见心肺疾病综合康复体系(NO.2018YFC2002300)

Source(s) of funding:

TCM Scientific Research Special Project of Sichuan TCM Administration (NO.2021MS055) Subproject of national Key RESEARCH and Development Program of Ministry of Science and Technology

Target disease:

disturbance of consciousness

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

主要目的:基于fNRIS技术探讨针刺促醒意识障碍患者的机制。  

Objectives of Study:

Main purpose: Based on fNRIS technology, the mechanism of acupuncture promoting consciousness disorder was discussed.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.符合上述慢性意识障碍诊断标准,包括Chronic Coma、VS/UWS、MCS阶段;
2.突发意识障碍,病因明确;
3.右利手;
4.年龄18岁≤年龄≤75岁;
5.生命体征平稳,未参加其它临床研究者;
6.获得患者法定代理人知情同意。

Inclusion criteria

1. Meet the above-mentioned diagnostic criteria for chronic disturbance of consciousness, including Chronic Coma, VS/UWS, and MCS stages;
2. Sudden disturbance of consciousness with clear etiology;
3. Right-handed;
4. Aged 18 to 75 years;
5. The vital signs are stable, and they have not participated in other clinical investigators;
6. Obtain the informed consent of the patient's legal representative.

排除标准:

1.合并颅内肿瘤、颅内感染发作期或脑死亡者;
2.脑损伤前有精神病史或吸毒、长期嗜酒史者;
3.既往有神经系统相关病史(神经退行性变、脑卒中等)者;
4.病情不稳定,呼吸、循环系统严重并发症未得到有效控制者;
5.有严重内分泌代谢疾病和其他占位性疾病等明显影响研究结果的患者;
6.发病后处于急性期,意识障碍病程未满1月者;
7.癫痫持续状态者;
8.妊娠、合并多发性创伤、四肢骨折或皮肤大面积缺损者;
9.有fNIRS采集禁忌者。

Exclusion criteria:

1. Complicated with intracranial tumor, intracranial infection episode or brain death;
2. Those who have a history of mental illness or drug or long-term alcohol addiction before brain injury;
3. Those who have a history of nervous system related diseases (neurodegeneration, stroke, etc.);
4. Patients with unstable condition and serious complications of respiratory and circulatory system have not been effectively controlled;
5. Patients with severe endocrine and metabolic diseases and other space-occupying diseases that significantly affect the research results;
6. Those who are in the acute phase after the onset of the disease, and the duration of the disorder of consciousness is less than 1 month;
7. Patients with status epilepticus;
8. Pregnancy, combined with multiple trauma, limb fracture or large area of skin defect;
9. Those with contraindications to fNIRS collection.

研究实施时间:

Study execute time:

From 2021-01-30 00:00:00 To 2022-10-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-11-20 00:00:00 To 2022-03-10 00:00:00  

干预措施:

Interventions:

组别:

试验组

样本量:

14

Group:

Experimental group1

Sample size:

干预措施:

针刺

干预措施代码:

Intervention:

acupuncture

Intervention code:

组别:

对照组

样本量:

14

Group:

Control group

Sample size:

干预措施:

假针刺

干预措施代码:

Intervention:

sham-acupuncture

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川 

市(区县):

成都 

Country:

China 

Province:

Sichuan 

City:

Chengdu 

单位(医院):

四川大学华西医院 

单位级别:

三级甲等 

Institution
hospital:

West China Hospital of Sichuan University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

近红外数据

指标类型:

主要指标

Outcome:

fNIRS data

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

昏迷康复评分修订版

指标类型:

次要指标

Outcome:

The Coma Recovery Scale–Revised

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

格拉斯哥昏迷评分

指标类型:

次要指标

Outcome:

Glasgow Coma Scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

No

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 75 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

按照随机数字表,随机分为两组,每组14组

Randomization Procedure (please state who generates the random number sequence and by what method):

According to the random number table, they were randomly divided into two groups with 14 groups in each group

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Not stated

Blinding:

Not stated

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

通过发表期刊文章公开原始数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

by publication

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-11-20 10:00:11